Kerx stock earnings

Keryx Biopharmaceuticals, Inc. (delisted) stock quote and KERX charts. Latest stock price today and the US's most active stock market forums. Keryx Biopharmaceuticals, Inc (KERX) Stock Message Board ... Sep 17, 2019 · Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of life-threatening diseases, including cancer and renal disease. Keryx is developing KRX-0401 (perifosine), a novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3 …

30 Year Financial Data of Keryx Biopharmaceuticals Inc ... 30 Year Financial Data of Keryx Biopharmaceuticals Inc KERX - GuruFocus.com KERX. Per Share Data Ratios Income (EBITDA, FCF, earnings) of the last 12 months over the per share NonCurrent Deferred Liabilities Other Long-Term Liabilities Total Liabilities Common Stock Preferred Stock Retained Earnings Accumulated other Keryx Biopharmaceuticals Inc. (KERX) Earnings KERX Financial Facts Total research and development: 8.67M Basic and diluted net loss per common share: -0.39 See Full Income Statement Accrued compensation and related liabilities: 4.92M Earnings News & Latest Company Earnings Results | Reuters.com Get the latest earnings news and financial highlights including earnings per share, quarterly results, revenue growth and loss. Keryx Biopharmaceuticals, Inc. (delisted) Stock Price - KERX

Keryx Biopharmaceuticals, Inc. (KERX) Earnings Report ...

Sep 17, 2019 · Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of life-threatening diseases, including cancer and renal disease. Keryx is developing KRX-0401 (perifosine), a novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3 … Kerx Earnings Archives - Stock News Union Kerx Earnings | Keryx Biopharmaceuticals (NASDAQ:KERX) fell 4.98% after the company reported wider than expected Q2 net loss of $0.22 cents a share. KERX: Keryx Biopharmaceuticals, Inc. (KERX): Earnings News Mar 01, 2017 · KERX had returned -14.16% year-to-date leading up to today’s news, versus a 0.00% return from the benchmark S&P 500 during the same period. More Info …

Keryx Biopharmaceuticals, Inc. (delisted) Stock Price - KERX

KERX Keryx Biopharmaceuticals, Inc. Earnings Date History and Options Price Movements Analysis Stock to Watch: Keryx Biopharmaceuticals (NASDAQ: KERX)

Get the latest earnings news and financial highlights including earnings per share, quarterly results, revenue growth and loss.

Jan 01, 2010 · Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance

KERX stock is 36.03% above its 52 week low. Our calculations result in a 200 day moving average of 3.98 and a 50 day moving average of 3.04. Right now, KERX stock is trading -15.58% below its 200 day moving average and may not be a great opportunity to buy as it may continue to trend down.

Dec 12, 2018 · Real-time trade and investing ideas on Keryx Biopharmaceuticals Inc. KERX from the largest community of traders and investors. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Keryx Biopharmaceuticals (KERX) Stock: Announces FDA ...

KERX Keryx Biopharmaceuticals Inc. — Stock Price and ... Dec 12, 2018 · Real-time trade and investing ideas on Keryx Biopharmaceuticals Inc. KERX from the largest community of traders and investors. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Keryx Biopharmaceuticals (KERX) Stock: Announces FDA ... Nov 07, 2017 · Keryx Biopharmaceuticals (NASDAQ: KERX) is having an overwhelmingly rough start to the trading session this morning, and for good reason. … 30 Year Financial Data of Keryx Biopharmaceuticals Inc ...